期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

IgA肾病患者胰岛素抵抗与炎症状态临床研究

Clinical Research on Insulin Resistance and Inflammation on Patients with IgA Nephropathy
下载PDF
导出
摘要 目的:探讨IgA肾病患者C反应蛋白与胰岛索抵抗的关系。方法:分别测定4组不同临床表现的83例IgA肾病患者的代谢指标和炎症指标。结果:IgA肾病患者炎症状态与胰岛素抵抗明显相关。结论:胰岛素抵抗和炎症状态是加速慢性肾脏病进展的因素。 Objective： To explore the correlation between C -reactive protein and insulin resistance on patients with IgA nephropathy. Methods： To test metabolic indicators and indicators of inflammation on four groups of different clinical manifestations of 83 cases of patients with IgA nephropathy. Results： Inflammatory situation is clearly associated with insulin resistance in patients with IgA nephropathy. Conclusion： Insulin resistance and inflammation situation are factors to accelerate the progress of chronic kidney disease.
作者 薛兰芬 罗增彦 聂丽敏 潘志兰
机构地区 河北省石家庄市第一医院肾内科 棉四职工医院
出处 《中国医药导刊》 2008年第4期605-606,共2页 Chinese Journal of Medicinal Guide
关键词 IGA肾病 胰岛素抵抗 C反应蛋白 IgA nephropathy Insulin resistance C- reactive protein
分类号 R692.3 [医药卫生—泌尿科学] R587.1 [医药卫生—内分泌]
  • 相关文献

参考文献5

  • 1任颖,陆广华,厉锦华,周桓,范吴强,黄定九.HOMA法和血糖钳夹法胰岛素抵抗指数的关系[J].上海第二医科大学学报,2002,22(4):325-326. 被引量：34
  • 2Smith NL, Psaty BM, Furberg CD, et al. Temporal trends in the use of anticoagulants among older adults with atrial fibril lation. Arch Intem Med, 1999; 159(14) :1574 - 1578
  • 3Hsu SI, Ramirez SB, Winn MP, et al. [ J ]. KidneyInt ,2000,57 (5) 1818 - 1835
  • 4Jing Chen, Paul Muntner, Lee Hamm, et al. Insulin - sistance and risk of chronic kidney disease in nondiabetic US adult [ J ]. J Am Soc Nephrol,2003 ; 14 ( 3 ) :469 - 447
  • 5Pickup JC, Matton MB, Chusney GD, et al. NIDDM as a disease of the innate immune system : association of acute phase reactants and interleukin - 6 with metabolic syndrome Ⅹ. Diabetologia, 2004 ;40 : 1286 - 1292

二级参考文献9

  • 1[1]Kirsten AM, Sheila MW, Jim IM, et al. Diagnosing insulin resistance in the general population[J]. Diabetes Care, 2001,24:460-464.
  • 2[2]Bonora E, Targher G, Alberiche M, et al. Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity[J]. Diabetes Care, 2000,23:57-63.
  • 3[3]Emoto M, Nishizawa K, Maekawa K, et al. Homeostasis model assessment as a clinical index of insulin resistance in type 2 diabetic patients treated with sulfonylureas[J]. Diabetes Care, 1999,22:818-822.
  • 4[4]Eatthewe OR, Hosker JR, Rudenski AS, et al. Homeostasis model assessment: insulin resistance and β-cell function from fasting glucose and insulin concentrations in man[J]. Diabetologgia, 1985,28:412-419.
  • 5[5]Yue TL, Chen J, Bao W, et al. In vivo myocardial protection from ischemia/reperfusion injury by the peroxisome proliferator-activated receptor-gamma agonist rosiglitazone[J]. Circulation, 2001, 104(21): 2588-2594.
  • 6[6]Mather KJ, Hunt AJ, Steinberg HO, et al. Repeatability characte_ ristics of simple indices of insulin resistance: implications for research applications[J]. J Clin Endocrinol Metab, 2001,86:5457-5464.
  • 7[7]Lansang MC, Williams GH, Carroll JS. Correlation between the glucose clamp technique and the homeostasis model assessment in hypertension[J]. Am J Hypertens, 2001, 14(1): 51-53.
  • 8[8]Taverna MJ, Pacher N,Bruzzo F, et al. Beta-cell function evaluated by HOMA as a predictor of secondary sulphonylurea failure in type 2 diabetes[J]. Diabet Med, 2001,18(7):584-587.
  • 9[9]Akira K, Yasuhiro S, Esteban CG, et al. Homeostasis model assessment is a reliable indicator of insulin resistance during follow-up of patients with type 2 diabetes[J]. Diabetes Care, 2001,24:362-365.

共引文献33

中国医药导刊
2008年 第4期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部